Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11413323 Ophthalmic composition for treatment of dry eye disease

Patent 11413323 was granted and assigned to Novaliq on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

1

Patent attributes

Patent Applicant

1

Current Assignee

1

Patent Jurisdiction

United States Patent and Trademark Office

1

Patent Number

Patent Inventor Names

Alice Meides1

Chiara Silvana Leo1

Sonja Krösser1

Thomas Schlüter1

Date of Patent

August 16, 2022

1

Patent Application Number

172283091

Date Filed

April 12, 2021

1

Patent Citations

US Patent 10130707 Topical pharmaceutical composition based on semifluorinated alkanes

US Patent 10045996 Pharmaceutical composition for treatment of increased intraocular pressure

Patent Citations Received

US Patent 12128010 Semifluorinated compounds and their compositions

4

US Patent 12005033 Compositions comprising mixtures of semifluorinated alkanes

5

Loading...

6

US Patent 12059449 Ophthalmic composition for treatment of dry eye disease

7

Patent Primary Examiner

Jeffrey T. Palenik

1

CPC Code

1

1

1

1

1

1

1

1

...

The invention provides ophthalmic compositions comprising about 0.1 % (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease. The invention further provides kits comprising such compositions for the same use.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11413323 Ophthalmic composition for treatment of dry eye disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool